Qx. Meng et al., Mutagenicity and loss of heterozygosity at the APRT locus in human lymphoblastoid cells exposed to 3 '-azido-3 '-deoxythymidine, MUTAGENESIS, 15(5), 2000, pp. 405-410
Previous experiments in our research group showed that 3'-azido-3'-deoxythy
midine (AZT) caused increased mutant frequencies (Mfs) at the X-linked hypo
xanthine-guanine phosphoribosyltransferase (HPRT) and the autosomal thymidi
ne kinase (TK) genes in human lymphoblastoid cells and that there was a sig
nificant positive correlation between AZT incorporation into cellular DNA a
nd AZT-induced TK Mfs, In the current study, the mutagenicity of AZT was fu
rther evaluated at the autosomal adenine phosphoribosyltransferase (APRT) g
ene, AZH1 cells, a human lymphoblastoid cell line heterozygous at the APRT
locus, were exposed to 300 mu M AZT for 0, 1, 3 or 6 days or to 0, 33, 100,
300 or 900 mu M AZT for 3 days (n = 5 flasks/group). A cell cloning assay
was used to quantitate APRT Mfs, AZT-induced APRT Mf increased with extende
d duration and with incremental concentrations of AZT exposure. There was a
positive correlation (P = 0.022, coefficient = 0.93) between AZT incorpora
tion into DNA and AZT-induced APRT Mfs, RFLP analyses indicated that AZT ex
clusively induced loss of heterozygosity in APRT mutants, These results, wh
ich are consistent with findings on the mutagenicity of AZT at the HPRT and
TK genes, indicate the need for further investigations on the potential lo
ng-term side effects of AZT on humans, especially those who receive AZT for
a prophylactic reason.